Shares of retailers and other consumer companies rose sharply amid growing optimism about the U.S. reopening.
"The Johnson & Johnson clot issue is delaying a key single dose and easily stored vaccine solution," said Edward Moya, senior market analyst at foreign exchange brokerage OANDA Group, in a note to clients.
"An abundance of caution could mean we lose a week or two with the J&J vaccine, with some fearing that it will fuel greater vaccine hesitancy given the recent concerns with the AstraZeneca one."
Write to Rob Curran at firstname.lastname@example.org
(END) Dow Jones Newswires